Thermostability and binding properties of single‐chained Fv fragments derived from therapeutic antibodies

Author:

Tadokoro Takashi12,Tsuboi Harumi1,Nakamura Kota1,Hayakawa Tetsushi1,Ohmura Reo1,Kato Izumi2,Inoue Masaki3,Tsunoda Shin‐ichi3,Niizuma Sayaka2,Okada Yukari2,Otsuguro Satoko2,Maenaka Katsumi1245ORCID

Affiliation:

1. Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences Hokkaido University Sapporo Japan

2. Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences Hokkaido University Sapporo Japan

3. Laboratory of Cellular and Molecular Physiology, The Faculty of Pharmaceutical Sciences Kobe Gakuin University Kobe Japan

4. Institute for Vaccine Research and Development (HU‐IVReD) Hokkaido University Sapporo Japan

5. Global Station for Biosurfaces and Drug Discovery Hokkaido University Sapporo Japan

Abstract

AbstractSmall antibody fragments have recently been used as alternatives to full‐length monoclonal antibodies in therapeutic applications. One of the most popular fragment antibodies is single‐chain fragment variables (scFvs), consisting of variable heavy (VH) and variable light (VL) domains linked by a flexible peptide linker. scFvs have small molecular sizes, which enables good tissue penetration and low immunogenicity. Despite these advantages, the use of scFvs, especially for therapeutic purpose, is still limited because of the difficulty to regulate the binding activity and conformational stability. In this study, we constructed and analyzed 10 scFv fragments derived from 10 representatives of FDA‐approved mAbs to evaluate their physicochemical properties. Differential scanning calorimetry analysis showed that scFvs exhibited relatively high but varied thermostability, from 50 to 70°C of melting temperatures, and different unfolding cooperativity. Surface plasmon resonance analysis revealed that scFvs fragments that exhibit high stability and cooperative unfolding likely tend to maintain antigen binding. This study demonstrated the comprehensive physicochemical properties of scFvs derived from FDA‐approved antibodies, providing insights into antibody design and development.

Funder

Japan Agency for Medical Research and Development

Takeda Science Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3